4.3 Review

Synthetic Applications and Methodological Developments of Donor-Acceptor Cyclopropanes and Related Compounds

期刊

ISRAEL JOURNAL OF CHEMISTRY
卷 56, 期 6-7, 页码 431-444

出版社

WILEY-V C H VERLAG GMBH
DOI: 10.1002/ijch.201500089

关键词

cycloaddition; cyclopropanes; fragmentation; heterocycles; rearrangement

资金

  1. A. P. Sloan Foundation
  2. Abbott
  3. American Cancer Society [JFRA-523]
  4. Amgen
  5. Astellas Pharma
  6. AstraZeneca
  7. Bayer Corporation
  8. Boehringer Ingelheim
  9. Bristol-Myers Squibb
  10. Caltech
  11. Camille and Henry Dreyfus Foundation
  12. Eli Lilly
  13. Elsa U. Pardee Foundation
  14. GlaxoSmithKline
  15. Johnson Johnson
  16. Merck
  17. NIH-NIGMS [R01GM080269]
  18. Novartis
  19. NSF CCI Center for Selective C-H Functionalization [CHE-1205646]
  20. Pfizer
  21. Research Corporation
  22. Roche
  23. Yale University
  24. Baylor University
  25. Welch Foundation (Chair) [AA-006]
  26. Cancer Prevention & Research Institute of Texas (CPRIT) [R1309]
  27. Direct For Mathematical & Physical Scien
  28. Division Of Chemistry [1205646] Funding Source: National Science Foundation

向作者/读者索取更多资源

Donor-acceptor cyclopropanes are convenient precursors to reactive and versatile 1,3-dipoles, and have found application in the synthesis of a variety of carbo- and heterocyclic scaffolds. This perspective review details our laboratory's use of donor-acceptor cyclopropanes as intermediates toward the total synthesis of various natural products. We also discuss our work in the development of novel cycloadditions and rearrangements of donor-acceptor cyclopropanes and aziridines, as well as an example of an aryne insertion proceeding via fragmentation of a transient donor-acceptor cyclobutane.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.3
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据